Apollo TMS Devices for Leading Healthcare Providers in America
A leading device in Transcranial Magnetic Stimulation, FDA-cleared for Major Depression (15+), Anxious Depression and OCD.
Are you looking to start or expand your TMS Practice?
neurocare's expert team in America works with Psychiatry teams, practice owners and clinical decision-makers to make Apollo TMS Therapy a success story, for both your patients and your business.
Introducing Apollo TMS Pro
✓ FDA‑cleared for Major Depression (15+) and OCD
✓ No pay‑per‑use or coil replacement fees
✓ Industry-leading biphasic pulse width
✓ Research-grade stimulator
✓ Easy-to-use software
.jpg?width=2000&height=1350&name=apollo-tms-pro-lounger%20(2).jpg)
Is your practice ready to take the next step?
Do you treat patients with depression who have not responded positively to other treatments?
Are your patients increasingly asking about non-pharmacological treatment options?
Do clinicians in your service regularly reach a point of needing to consider alternative care pathways or treatment escalation?
If so, Apollo TMS Therapy might be a feasible next step for your practice.
Superior business model for modern clinics
Apollo TMS Pro operates on a clear capital ownership model, with no usage‑based or coil replacement fees. This approach supports predictable operating costs as clinics scale TMS services over time.
Engineered for reliability and daily throughput, the system integrates smoothly into established clinic workflows.
Training, onboarding, and ongoing support
Installation includes structured training for clinical and technical teams, supporting confident system adoption from day one.
Clinics have continued access to neurocare’s experienced clinical, technical, and engineering support teams throughout the system lifecycle.
Trusted by over 350+ clinics advancing TMS care
Apollo TMS supports a growing network of clinics delivering Transcranial Magnetic Stimulation in clinical practice.
Are you a patient looking for best-practice TMS Treatment?
